Insights into gene expression changes impacting B-cell transformation: Cross-species microarray analysis of bovine leukemia virus tax-responsive genes in ovine B cells

Journal of Virology

Volumn 80, Issue 4, 2006, Pages 1922-1938

  Klener, Pavel ^a,b   Szynal, Maud ^a   Cleuter, Yvette ^a   Merimi, Makram ^a   Duvillier, Hugues ^a   Lallemand, Françoise ^a   Bagnis, Claude ^c   Griebel, Philip ^d   Sotiriou, Christos ^a   Burny, Arsène ^a   Martiat, Philippe ^a   Van Den Broeke, Anne ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b CHARLES UNIVERSITY   (Czech Republic)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ONCOPROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BOVINE LEUKEMIA VIRUS; CATTLE; CELL TRANSFORMATION; DNA MICROARRAY; DNA REPAIR; DNA TRANSCRIPTION; EXPRESSED SEQUENCE TAG; GENE EXPRESSION REGULATION; HUMAN T CELL LEUKEMIA VIRUS 1; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTO ONCOGENE; SPECIES DIFFERENTIATION; TRANSACTIVATION; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; VIRUS CHARACTERIZATION; VIRUS TRANSMISSION;

ANIMALS; B-LYMPHOCYTES; BLOTTING, NORTHERN; CELL TRANSFORMATION, VIRAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE PRODUCTS, TAX; HUMANS; LEUKEMIA VIRUS, BOVINE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SHEEP;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE LEUKEMIA VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; OVIS; OVIS ARIES;

EID: 32444450151     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.80.4.1922-1938.2006     Document Type: Article

References (85)

1. Akasaka, T., I. S. Lossos, and R. Levy. 2003. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 102:1443-1448.
2. Albagli-Curiel, O. 2003. Ambivalent role of BCL6 in cell survival and transformation. Oncogene 22:507-516.
3. Baum, C., S. Hegewisch-Becker, H. G. Eckert, C. Stocking, and W. Ostertag. 1995. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells. J. Virol. 69:7541-7547.
4. Brady, J., K. T. Jeang, J. Duvall, and G. Khoury. 1987. Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat. J. Virol. 61:2175-2181.
5. Bulavin, D. V., O. N. Demidov, S. Saito, P. Kauraniemi, C. Phillips, S. A. Amundson, C. Ambrosino, G. Sauter, A. R. Nebreda, C. W. Anderson, A. Kallioniemi, A. J. Fornace, Jr., and E. Appella. 2002. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 31:210-215.
6. Burny, A., L. Willems, I. Callebaut, E. Adam, I. Cludts, I. F. Dequiedt, L. Droogmans, C. Grimonpont, P. Kerkhofs, M. Mammerickx, D. Portetelle, A. Van den Broeke, and R. Kettman. 1994. Bovine leukemia virus: biology and mode of transformation, p. 313-334. In A. C. Minson, J. C. Neil, and M. A. McRae (ed.), Viruses and cancer. Cambridge University Press, Cambridge, United Kingdom.
7. Butt, E., S. Gambaryan, N. Gottfert, A. Galler, K. Marcus, and H. E. Meyer. 2003. Actin binding of human LIM and SH3 protein is regulated by cGMP- and cAMP-dependent protein kinase phosphorylation on serine 146. J. Biol. Chem. 278:15601-15607.
8. Chismar, J. D., T. Mondala, H. S. Fox, E. Roberts, D. Langford, E. Masliah, D. R. Salomon, and S. R. Head. 2002. Analysis of result variability from high-density oligonucleotide arrays comparing same-species and cross-species hybridizations. BioTechniques 33:516-518, 520, 522.
9. Coussens, P. M., and W. Nobis. 2002. Bioinformatics and high throughput approach to create genomic resources for the study of bovine immunobiology. Vet. Immunol. Immunopathol. 86:229-244.
10. Derse, D. 1987. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements. J. Virol. 61:2462-2471.
11. Eberwine, J. 1996. Amplification of mRNA populations using aRNA generated from immobilized oligo(dT)-T7 primed cDNA. BioTechniques 20:584-591.
12. Franchini, G. 1995. Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. Blood 86:3619-3639.
13. Furukawa, K., T. Iioka, M. Morishita, A. Yamaguchi, H. Shindo, H. Namba, S. Yamashita, and T. Tsukazaki. 2002. Functional domains of paired-like homeoprotein Cart1 and the relationship between dimerization and transcription activity. Genes Cells 7:1135-1147.
14. Gatza, M. L., J. C. Watt, and S. J. Marriott. 2003. Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades. Oncogene 22:5141-5149.
15. Geerts, D., N. Schilderink, G. Jorritsma, and R. Versteeg. 2003. The role of the MEIS homeobox genes in neuroblastoma. Cancer Lett. 197:87-92.
16. Goodman, R. H., and S. Smolik. 2000. CBP/p300 in cell growth, transformation, and development. Genes Dev. 14:1553-1577.
17. Grassmann, R., S. Berchtold, I. Radant, M. Alt, B. Fleckenstein, J. G. Sodroski, W. A. Haseltine, and U. Ramstedt. 1992. Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 66:4570-4575.
18. Griebel, P., T. Beskorwayne, D. L. Godson, Y. Popowych, and W. Hein. 2000. Cloning non-transformed sheep B cells. J. Immunol. Methods 237:19-28.
19. Griebel, P., T. Beskorwayne, A. Van den Broeke, and G. Ferrari. 1999. CD40 signaling induces B cell responsiveness to multiple members of the gamma chain-common cytokine family. Int. Immunol. 11:1139-1147.
20. Gu, L., H. W. Findley, and M. Zhou. 2002. MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia. Blood 99:3367-3375.
21. Gurevich, R. M., P. D. Aplan, and R. K. Humphries. 2004. NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation. Blood 104:1127-1136.
22. Hai, T., and T. Curran. 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88:3720-3724.
23. Hakoshima, T., T. Shimizu, and R. Maesaki. 2003. Structural basis of the Rho GTPase signaling. J. Biochem. (Tokyo) 134:327-331.
24. Hawkins, R. D., S. Bashiardes, C. A. Helms, L. Hu, N. L. Saccone, M. E. Warchol, and M. Lovett. 2003. Gene expression differences in quiescent versus regenerating hair cells of avian sensory epithelia: implications for human hearing and balance disorders. Hum. Mol. Genet. 12:1261-1272.
25. Hermeking, H. 2003. Serial analysis of gene expression and cancer. Curr. Opin. Oncol. 15:44-49.
26. Higgins, M. A., B. R. Berridge, B. J. Mills, A. E. Schultze, H. Gao, G. H. Searfoss, T. K. Baker, and T. P. Ryan. 2003. Gene expression analysis of the acute phase response using a canine microarray. Toxicol. Sci. 74:470-484.
27. Holleman, A., M. H. Cheok, M. L. den Boer, W. Yang, A. J. Veerman, K. M. Kazemier, D. Pei, C. Cheng, C. H. Pui, M. V. Relling, G. E. Janka-Schaub, R. Pieters, and W. E. Evans. 2004. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N. Engl. J. Med. 351:533-542.
28. Hsu, S. I., C. M. Yang, K. G. Sim, D. M. Hentschel, E. O'Leary, and J. V. Bonventre. 2001. TRIP-Br: a novel family of PHD zinc finger- and bromo-domain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1. EMBO J. 20:2273-2285.
29. Iioka, T., K. Furukawa, A. Yamaguchi, H. Shindo, S. Yamashita, and T. Tsukazaki. 2003. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain. J. Bone Miner. Res. 18:1419-1429.
30. Janoueix-Lerosey, I., E. Novikov, M. Monteiro, N. Gruel, G. Schleiermacher, B. Loriod, C. Nguyen, and O. Delattre. 2004. Gene expression profiling of 1p35-36 genes in neuroblastoma. Oncogene 23:5912-5922.
31. Ji, W., W. Zhou, K. Gregg, N. Yu, S. Davis, and S. Davis. 2004. A method for cross-species gene expression analysis with high-density oligonucleotide arrays. Nucleic Acids Res. 32:e93.
32. Kanno, T., H. Endo, K. Takeuchi, Y. Morishita, M. Fukayama, and S. Mori. 2002. High expression of methionine aminopeptidase type 2 in germinal center B cells and their neoplastic counterparts. Lab. Investig. 82:893-901.
33. Khoury, J. D., L. J. Medeiros, G. Z. Rassidakis, T. J. McDonnell, L. V. Abruzzo, and R. Lai. 2003. Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression. J. Pathol. 199:90-97.
34. Kroes, R. A., A. Jastrow, M. G. McLone, H. Yamamoto, P. Colley, D. S. Kersey, V. W. Yong, E. Mkrdichian, L. Cerullo, J. Leestma, and J. R. Moskal. 2000. The identification of novel therapeutic targets for the treatment of malignant brain tumors. Cancer Lett. 156:191-198.
35. Lawrence, B., A. Perez-Atayde, M. K. Hibbard, B. P. Rubin, P. Dal Cin, J. L. Pinkus, G. S. Pinkus, S. Xiao, E. S. Yi, C. D. Fletcher, and J. A. Fletcher. 2000. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am. J. Pathol. 157:377-384.
36. Lemoine, F. J., D. R. Wycuff, and S. J. Marriott. 2001. Transcriptional activity of HTLV-I Tax influences the expression of marker genes associated with cellular transformation. Dis. Markers 17:129-137.
37. Lerner, A., D. H. Kim, and R. Lee. 2000. The cAMP signaling pathway as a therapeutic target in lymphoid malignancies. Leuk. Lymphoma 37:39-51.
38. Li, B., T. Fink, P. Ebbesen, X. D. Liu, and V. Zachar. 2003. Expression of butyrate response factor 1 in HTLV-1-transformed cells and its transactivation by Tax protein. Arch. Virol. 148:1787-1804.
39. Li, X., and B. Lim. 2003. RhoGTPases and their role in cancer. Oncol. Res. 13:323-331.
40. Maass, N., F. Rosel, C. Schem, J. Hitomi, W. Jonat, and K. Nagasaki. 2002. Amplification of the BCAS2 gene at chromosome 1p13.3-21 in human primary breast cancer. Cancer Lett. 185:219-223.
41. Mackay, A., C. Jones, T. Dexter, R. L. Silva, K. Bulmer, A. Jones, P. Simpson, R. A. Harris, P. S. Jat, A. M. Neville, L. F. Reis, S. R. Lakhani, and M. J. O'Hare. 2003. cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells. Oncogene 22:2680-2688.
42. Mammerickx, M., R. Palm, D. Portetelle, and A. Burny. 1988. Experimental transmission of enzootic bovine leukosis to sheep: latency period of the tumoral disease. Leukemia 2:103-107.
43. Martin, M. E., T. A. Milne, S. Bloyer, K. Galoian, W. Shen, D. Gibbs, H. W. Brock, R. Slany, and J. L. Hess. 2003. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 4:197-207.
44. Martini, A., R. La Starza, H. Janssen, C. Bilhou-Nabera, A. Corveleyn, R. Somers, A. Aventin, R. Foa, A. Hagemeijer, C. Mecucci, and P. Marynen. 2002. Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia. Cancer Res. 62:5408-5412.
45. Matsuoka, M. 2003. Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 22:5131-5140.
46. Michaud, J., H. S. Scott, and R. Escher. 2003. AML1 interconnected pathways of leukemogenesis. Cancer Investig. 21:105-136.
47. Moody, D. E., Z. Zou, and L. McIntyre. 2002. Cross-species hybridisation of pig RNA to human nylon microarrays. BMC Genomics 3:27.
48. Moon, E., R. Lee, R. Near, L. Weintraub, S. Wolda, and A. Lerner. 2002. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia. Clin. Cancer Res. 8:589-595.
49. Nagata, T., Y. Takahashi, Y. Ishii, S. Asai, Y. Nishida, A. Murata, T. Koshinaga, M. Fukuzawa, M. Hamazaki, K. Asami, E. Ito, H. Ikeda, H. Takamatsu, K. Koike, A. Kikuta, M. Kuroiwa, A. Watanabe, Y. Kosaka, H. Fujita, M. Miyake, and H. Mugishima. 2003. Transcriptional profiling in hepatoblastomas using high-density oligonucleotide DNA array. Cancer Genet. Cytogenet. 145:152-160.
50. Ng, P. W., H. Iha, Y. Iwanaga, M. Bittner, Y. Chen, Y. Jiang, G. Gooden, J. M. Trent, P. Meltzer, K. T. Jeang, and S. L. Zeichner. 2001. Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-kappaB activation. Oncogene 20:4484-4496.
51. Okamoto, H., K. Yasui, C. Zhao, S. Arii, and J. Inazawa. 2003. PTK2 and EIF3S3 genes may be amplification targets at 8q23-q24 and are associated with large hepatocellular carcinomas. Hepatology 38:1242-1249.
52. Pasqualucci, L., P. Neumeister, T. Goossens, G. Nanjangud, R. S. Chaganti, R. Kuppers, and R. Dalla-Favera. 2001. Hypermutation of multiple protooncogenes in B-cell diffuse large-cell lymphomas. Nature 412:341-346.
53. Pedersen, I. M., S. Kitada, L. M. Leoni, J. M. Zapata, J. G. Karras, N. Tsukada, T. J. Kipps, Y. S. Choi, F. Bennett, and J. C. Reed. 2002. Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1. Blood 100:1795-1801.
54. Peng, Y. C., D. E. Breiding, F. Sverdrup, J. Richard, and E. J. Androphy. 2000. AMF-1/Gps2 binds p300 and enhances its interaction with papillomavirus E2 proteins. J. Virol. 74:5872-5879.
55. Poppe, B., J. Vandesompele, C. Schoch, C. Lindvall,. K. Mrozek, C. D. Bloomfield, H. B. Beverloo, L. Michaux, N. Dastugue, C. Herens, N. Yigit, A. De Paepe, A. Hagemeijer, and F. Speleman. 2004. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood 103:229-235.
56. Pourquier, P., and Y. Pommier. 2001. Topoisomerase I-mediated DNA damage. Adv. Cancer Res. 80:189-216.
57. Pozzatti, R., J. Vogel, and G. Jay. 1990. The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol. Cell. Biol. 10:413-417.
58. Rassidakis, G. Z., R. Lai, T. J. McDonnell, F. Cabanillas, A. H. Sarris, and L. J. Medeiros. 2002. Overexpression of Mcl-1 in anaplastic large cell lymphoma cell lines and tumors. Am. J. Pathol. 160:2309-2310.
59. Russo, G., C. Zegar, and A. Giordano. 2003. Advantages and limitations of microarray technology in human cancer. Oncogene 22:6497-6507.
60. Sahai, E., and C. J. Marshall. 2002. RHO-GTPases and cancer. Nat. Rev. Cancer 2:133-142.
61. Schuch, G., M. Machluf, G. Bartsch, Jr., M. Nomi, H. Richard, A. Atala, and S. Soker. 2002. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood 100:4622-4628.
62. Schwarze, S. R., S. E. DePrimo, L. M. Grabert, V. X. Fu, J. D. Brooks, and D. F. Jarrard. 2002, Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J. Biol. Chem. 277:14877-14883.
63. Strehl, S., A. Borkhardt, R. Slany, U. E. Fuchs, M. Konig, and O. A. Haas. 2003. The human LASP1 gene is fused to MLL in an acute myeloid leukemia with t(11;17)(q23;q21). Oncogene 22:157-160.
64. Su, Y. A., M. M. Lee, C. M. Hutter, and P. S. Meltzer. 1997. Characterization of a highly conserved gene (OS4) amplified with CDK4 in human sarcomas. Oncogene 15:1289-1294.
65. Szynal, M., Y. Cleuter, T. Beskorwayne, C. Bagnis, C. Van Lint, P. Kerkhofs, A. Burny, P. Martiat, P. Griebel, and A. Van den Broeke. 2003. Disruption of B-cell homeostatic control mediated by the BLV-Tax oncoprotein: association with the upregulation of Bcl-2 and signaling through NF-kappaB. Oncogene 22:4531-4542.
66. Tao, W., B. Mallard, N. Karrow, and B. Bridle. 2004. Construction and application of a bovine immune-endocrine cDNA microarray. Vet. Immunol. Immunopathol. 101:1-17.
67. Uranishi, H., T. Tetsuka, M. Yamashita, K. Asamitsu, M. Shimizu, M. Itoh, and T. Okamoto. 2001. Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. J. Biol. Chem. 276:13395-13401.
68. Vaarala, M. H., K. S. Porvari, A. P. Kyllonen, M. V. Mustonen, O. Lukkarinen, and P. T. Vihko. 1998. Several genes encoding ribosomal proteins are overexpressed in prostate-cancer cell lines: confirmation of L7a and L37 overexpression in prostate-cancer tissue samples. Int. J. Cancer 78:27-32.
69. Van den Broeke, A., C. Bagnis, M. Ciesiolka, Y. Cleuter, H. Gelderblom, P. Kerkhofs, P. Griebel, P. Mannoni, and A. Burny. 1999. In vivo rescue of a silent tax-deficient bovine leukemia virus from a tumor-derived ovine B-cell line by recombination with a retrovirally transduced wild-type tax gene. J. Virol. 73:1054-1065.
70. Van den Broeke, A., Y. Cleuter, T. Beskorwayne, P. Kerkhofs, M. Szynal, C. Bagnis, A. Burny, and P. Griebel. 2001. CD154 costimulated ovine primary B cells, a cell culture system that supports productive infection by bovine leukemia virus. J. Virol. 75:1095-1103.
71. Van den Broeke, A., Y. Cleuter, G. Chen, D. Portetelle, M. Mammerickx, D. Zagury, M. Fouchard, L. Coulombel, R. Kettmann, and A. Burny. 1989. Even transcriptionally competent proviruses are silent in bovine leukemia virus induced tumor cells. Proc. Natl. Acad. Sci. USA 85:9263-9267.
72. Visvader, J. E., D. Venter, K. Hahm, M. Santamaria, E. Y. Sum, L. O'Reilly, D. White, R. Williams, J. Armes, and G. J. Lindeman. 2001. The LIM domain gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and is overexpressed in breast cancer. Proc. Natl. Acad. Sci. USA 98:14452-14457.
73. Wang, Y., D. Cheong, S. Chan, and S. C. Hooi. 2000. Ribosomal protein L7a gene is up-regulated but not fused to the tyrosine kinase receptor as chimeric trk oncogene in human colorectal carcinoma. Int. J. Oncol. 16:757-762.
74. Weber, P. J., C. P. Eckhard, S. Gonser, H. Otto, G. Folkers, and A. G. Beck-Sickinger. 1999. On the role of thymopoietins in cell proliferation. Immunochemical evidence for new members of the human thymopoietin family. Biol. Chem. 380:653-660.
75. Willems, L., A. Burny, D. Collete, O. Dangoisse, F. Dequiedt, J. S. Gatot, P. Kerkhofs, L. Lefebvre, C. Merezak, T. Peremans, D. Portetelle, J. C. Twizere, and R. Kettmann. 2000. Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res. Hum. Retrovir. 16:1787-1795.
76. Willems, L., A. Gegonne, G. Chen, A. Burny, R. Kettmann, and J. Ghysdael. 1987. The bovine leukemia virus p34 is a transactivator protein. EMBO J. 6:3385-3389.
77. Willems, L., H. Heremans, G. Chen, D. Portetelle, A. Billiau, A. Burny, and R. Kettmann. 1990. Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J. 9:1577-1581.
78. Willems, L., R. Kettmann, F. Dequiedt, D. Portetelle, V. Voneche, I. Cornil, P. Kerkhofs, A. Burny, and M. Mammerickx. 1993. In vivo infection of sheep by bovine leukemia virus mutants. J. Virol. 67:4078-4085.
79. Wu, K., M. E. Bottazzi, C. de la Fuente, L. Deng, S. D. Gitlin, A. Maddukuri, S. Dadgar, H. Li, A. Vertes, A. Pumfery, and F. Kashanchi. 2004. Protein profile of tax-associated complexes. J. Biol. Chem. 279:495-508.
80. Yoshida, M. 2001. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu. Rev. Immunol. 19:475-496.
81. Zeng, S. X., M. S. Dai, D. M. Keller, and H. Lu. 2002. SSRP1 functions as a co-activator of the transcriptional activator p63. EMBO J. 21:5487-5497.
82. Zhang, Y., N. Woodford, X. Xia, and A. W. Hamburger. 2003. Repression of E2F1-mediated transcription by the ErbB3 binding protein Ebp1 involves histone deacetylases. Nucleic Acids Res. 31:2168-2177.
83. Zhao, F., R. McCarrick-Walmsley, P. Akerblad, M. Sigvardsson, and T. Kadesch. 2003. Inhibition of p300/CBP by early B-cell factor. Mol. Cell. Biol. 23:3837-3846.
84. Zhou, P., N. B. Levy, H. Xie, L. Qian, C. Y. Lee, R. D. Gascoyne, and R. W. Craig. 2001. MCL1 transgenic mice exhibit a high incidence of B-cell lymphoma manifested as a spectrum of histologic subtypes. Blood 97:3902-3909.
85. Zhu, Y., H. Lin, Z. Li, M. Wang, and J. Luo. 2001. Modulation of expression of ribosomal protein L7a (rpL7a) by ethanol in human breast cancer cells. Breast Cancer Res. Treat. 69:29-38.